These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1911364)

  • 1. Absence of graft-versus-leukemia (GVL) effect by leucocytes transfused: a prospective randomized trial in acute myeloid leukemia (AML) patients.
    Norol F; Parquet N; Kuentz M; Bierling P; Cordonnier C; Beaujean F; Duedari N; Vernant JP
    Br J Haematol; 1991 Aug; 78(4):591-3. PubMed ID: 1911364
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor leukocyte infusions in myeloid malignancies: new strategies.
    Porter DL; Antin JH
    Best Pract Res Clin Haematol; 2006; 19(4):737-55. PubMed ID: 16997180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia: management of relapse after allogeneic bone marrow transplantation.
    Kumar L
    J Clin Oncol; 1994 Aug; 12(8):1710-7. PubMed ID: 8040682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fate of transfused leukocytes obtained from chronic myeloleukemia patients].
    Petukhov VI; Piatkin EK
    Probl Gematol Pereliv Krovi; 1973 Apr; 18(4):26-30. PubMed ID: 4587779
    [No Abstract]   [Full Text] [Related]  

  • 5. Autografting for chronic granulocytic leukemia.
    Goldman JM; Johnson SA; Catovsky D; Wareham NJ; Galton DA
    N Engl J Med; 1981 Sep; 305(12):700. PubMed ID: 6943426
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?
    Dawson MA; Avery S; McQuilten ZK; Bailey MJ; Shortt J; Polizzotto MN; Wood EM; Cole-Sinclair MF
    Haematologica; 2007 Jul; 92(7):996-7. PubMed ID: 17606456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute "graft-versus-host disease" after autografting for chronic granulocytic leukemia in transformation.
    Thein SL; Goldman JM; Galton DA
    Ann Intern Med; 1981 Feb; 94(2):210-1. PubMed ID: 6937154
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse.
    Choi SJ; Lee JH; Lee JH; Kim S; Seol M; Lee YS; Lee JS; Kim WK; Chi HS; Lee KH
    Leukemia; 2004 Nov; 18(11):1789-97. PubMed ID: 15385924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation.
    van der Straaten HM; Fijnheer R; Nieuwenhuis HK; van de Winkel JG; Verdonck LF
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):206-12. PubMed ID: 15744239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation.
    Baron F; Labopin M; Ruggeri A; Mohty M; Sanz G; Milpied N; Bacigalupo A; Rambaldi A; Bonifazi F; Bosi A; Sierra J; Yakoub-Agha I; Santasusana JM; Gluckman E; Nagler A
    J Hematol Oncol; 2015 Oct; 8():107. PubMed ID: 26445106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Saso R; Mehta J
    Leuk Lymphoma; 1999 Feb; 32(5-6):505-12. PubMed ID: 10048423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
    Grigg AP; Gibson J; Bardy PG; Reynolds J; Shuttleworth P; Koelmeyer RL; Szer J; Roberts AW; To LB; Kennedy G; Bradstock KF
    Biol Blood Marrow Transplant; 2007 May; 13(5):560-7. PubMed ID: 17448915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation.
    Mehta J; Powles R; Singhal S; Tait D; Swansbury J; Treleaven J
    Bone Marrow Transplant; 1995 Jul; 16(1):133-7. PubMed ID: 7581113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia.
    Alavi JB; Root RK; Djerassi I; Evans AE; Gluckman SJ; MacGregor RR; Guerry D; Schreiber AD; Shaw JM; Koch P; Cooper RA
    N Engl J Med; 1977 Mar; 296(13):706-11. PubMed ID: 320477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with donor leukocyte infusions for patients with relapsed acute myeloid leukemia following partially mismatched related donor bone marrow transplantation.
    Pati AR; Godder K; Lamb L; Gee A; Henslee-Downey PJ
    Bone Marrow Transplant; 1995 Jun; 15(6):979-81. PubMed ID: 7581101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion or transplantation?
    van Bekkum DW
    Isr J Med Sci; 1965 Sep; 1(5):879-82. PubMed ID: 5218620
    [No Abstract]   [Full Text] [Related]  

  • 18. [Remission of acute leukemia treated with exsanguination transfusion].
    CHVAPIL J; KOHN E
    Cas Lek Cesk; 1951 Aug; 90(34):1020-3. PubMed ID: 14870181
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogenic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay.
    Ogawa H; Tsuboi A; Oji Y; Tamaki H; Soma T; Inoue K; Sugiyama H
    Bone Marrow Transplant; 1998 Mar; 21(5):525-7. PubMed ID: 9535047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy and leucopheresis in chronic granulocytic leukaemia.
    Spiers AS; Tattersall MH; Galton DA
    Br Med J; 1973 Jun; 2(5866):610. PubMed ID: 4514789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.